Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension
- 1 November 2017
- journal article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 112, 376-386
Abstract
No abstract availableKeywords
Funding Information
- PRIN (201228PNX83)
- FUR_UNIVR (LDF) (2016_2017)
This publication has 55 references indexed in Scilit:
- Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic miceHaematologica, 2013
- The interplay between autophagy and ROS in tumorigenesisFrontiers in Oncology, 2012
- Endothelin-1, the Unfolded Protein Response, and Persistent InflammationAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Is Overoxidation of Peroxiredoxin Physiologically Significant?2011
- Mesenchymal Stromal Cells Expressing Heme Oxygenase-1 Reverse Pulmonary HypertensionStem Cells, 2010
- Disrupted postnatal lung development in heme oxygenase-1 deficient miceRespiratory Research, 2010
- Peroxiredoxin-2 expression is increased in β-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stressFree Radical Biology and Medicine, 2010
- Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell diseaseJournal of Clinical Investigation, 2008
- Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shockJournal of Experimental Medicine, 2007
- Autophagy Counterbalances Endoplasmic Reticulum Expansion during the Unfolded Protein ResponsePLOS Biology, 2006